Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R Leaker

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 26, 2014
Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmaticsZ Diamant, P N Sidharta, D Singh, et al.
BMJ Open Respiratory Research|July 13, 2016
A novel flow cytometric-based method to measure kinase inhibition in sputum from COPD subjectsG C Nicholson, R A Holloway, B R Leaker, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 22, 2014
The effects of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild-to-moderate asthmaB R Leaker, P J Barnes, B J O'Connor, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2007
Pharmacological modulation of gut mucosal and large vessel blood flowM A Kamm, C C Jordan, B R Leaker, et al.
Allergy|November 4, 2005
Single dose topical corticosteroid inhibits IL-5 and IL-13 in nasal lavage following grass pollen challengeE M Erin, B R Leaker, A S Zacharasiewicz, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 25, 2006
Effects of a reversible beta-tryptase and trypsin inhibitor (RWJ-58643) on nasal allergic responsesE M Erin, B R Leaker, A Zacharasiewicz, et al.
Mucosal Immunology|September 29, 2016
The nasal mucosal late allergic reaction to grass pollen involves type 2 inflammation (IL-5 and IL-13), the inflammasome (IL-1β), and complementB R Leaker, V A Malkov, R Mogg, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 26, 2014
Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmaticsZ Diamant, P N Sidharta, D Singh, et al.
BMJ Open Respiratory Research|July 13, 2016
A novel flow cytometric-based method to measure kinase inhibition in sputum from COPD subjectsG C Nicholson, R A Holloway, B R Leaker, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 22, 2014
The effects of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild-to-moderate asthmaB R Leaker, P J Barnes, B J O'Connor, et al.
Alimentary Pharmacology & Therapeutics|February 22, 2007
Pharmacological modulation of gut mucosal and large vessel blood flowM A Kamm, C C Jordan, B R Leaker, et al.
Allergy|November 4, 2005
Single dose topical corticosteroid inhibits IL-5 and IL-13 in nasal lavage following grass pollen challengeE M Erin, B R Leaker, A S Zacharasiewicz, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 25, 2006
Effects of a reversible beta-tryptase and trypsin inhibitor (RWJ-58643) on nasal allergic responsesE M Erin, B R Leaker, A Zacharasiewicz, et al.
Mucosal Immunology|September 29, 2016
The nasal mucosal late allergic reaction to grass pollen involves type 2 inflammation (IL-5 and IL-13), the inflammasome (IL-1β), and complementB R Leaker, V A Malkov, R Mogg, et al.
Pageof 2